Javid Fazili is a Gastroenterology physician affiliated with University of Oklahoma Health Sciences Center. OpenAlex indexes 47 publications with 575 citations (h-index 12).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
825 NE 10th St
Oupb 2300
Oklahoma City, OK 731045417
Telephone
405-271-8478Registry record last updated 18 Jan 2011.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Olympus America Inc.Program year20254 payments
- Janssen Biotech, Inc.Program year20253 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
80.6%Osmotic Laxative80.6%Gavilyte-C75%Peg-3350 And Electrolytes25%Part D≥55 patientsBlood & clotting
19.4%Solutions for parenteral nutrition19.4%Peg 3350-Electrolyte100%Part D≥18 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- From Inflammation to Oncogenesis: Tracing Serum DCLK1 and miRNA Signatures in Chronic Liver Diseases
International Journal of Molecular Sciences
2024 - S3801 Meckel’s Diverticulum: A Cause of Unknown Hemorrhagic Shock
The American Journal of Gastroenterology
2024 - S3961 Common Variable Immunodeficiency Mimicking Inflammatory Bowel Disease
The American Journal of Gastroenterology
2024 - Severe Hyperbilirubinemia as a Side Effect of Three-Week Treatment with Glecaprevir/Pibrentasvir Resulting in Sustained Virologic Response
Gastroenterology Hepatology & Digestive Disorders
2020
Similar KOLs
Other experts from the same institution or the same specialty.
Ira Targoff, MD
University of Oklahoma Health Sciences Center
Harold Burkhart, MD
University of Oklahoma Health Sciences Center
Steven Chernausek, MD
University of Oklahoma Health Sciences Center
Udho Thadani, MD
University of Oklahoma Health Sciences Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”